{"product_id":"auroramj-business-model-canvas","title":"Aurora Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAurora Business Model Canvas: Strategic Blueprint for Value, Growth \u0026amp; Competitive Edge\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock the full strategic blueprint behind Aurora’s business model—this in-depth Business Model Canvas exposes how the company creates value, scales revenue streams, and navigates competitive pressure; ideal for entrepreneurs, investors, and consultants seeking practical, actionable strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Medical Distributors\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAurora partners with overseas distributors like MedReleaf Australia and EU pharmacy networks to enter high-growth markets, using their local regulatory know-how to deliver pharmaceutical-grade cannabis; these alliances supported 42% of Aurora’s FY2025 export volumes (Q4 2025 company filings). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBevo Farms and Propagation Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe Bevo Farms acquisition gave Aurora an in-house propagation arm supplying ~2.4 million seedlings annually (2025 run-rate), stabilizing plant input costs by ~18% vs. spot purchases and smoothing seasonal demand swings tied to cannabis cycles.\u003c\/p\u003e\n\u003cp\u003eThis widens revenue exposure into the $220B global horticulture market, cuts nursery-to-cultivation lead time by 30%, and improves internal yield forecasts and cultivation efficiency.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Research Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaboration with academic centers and CROs drives Aurora’s evidence-based cannabis programs; since 2023 Aurora funded or co-sponsored 12 clinical trials, generating \u0026gt;1,800 patient data points used in peer-reviewed publications.\u003c\/p\u003e\n\u003cp\u003eThese partnerships supply scientific validation for clinicians and regulators, and Aurora’s proprietary trial outcomes and IP-backed datasets strengthen its competitive moat and commercial pricing, contributing to a 2024 R\u0026amp;D-to-revenue ratio of ~8.5%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment and Regulatory Agencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMaintaining proactive ties with Health Canada and Germany’s BfArM secures Aurora’s license to operate; these regulators set GMP production, potency testing, and export rules that Aurora must meet to ship to markets that grew cannabis-derived exports to CA$120m in 2024.\u003c\/p\u003e\n\u003cp\u003eContinuous engagement keeps Aurora ahead of policy shifts as over 40 countries updated medical cannabis rules by 2024, reducing regulatory delays and protecting export revenue.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHealth Canada: GMP, lot testing, sales reporting\u003c\/li\u003e\n\u003cli\u003eBfArM: import permits, product authorization\u003c\/li\u003e\n\u003cli\u003e2024 exports: CA$120m (industry figure)\u003c\/li\u003e\n\u003cli\u003e40+ countries updated rules by 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail and Provincial Wholesale Boards\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpaurora relies on provincial liquor and cannabis boards as primary distributors in canada with these government wholesalers controlling shelf access inventory across provinces canadian recreational retail sales reached about cad billion making relationships crucial for share. managing high-volume contracts logistics entities like the ontario store alberta gaming reduced out-of-stock rates to under best quarters so retention matters revenue.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 Canadian recreational cannabis retail sales ~CAD 4.5B\u003c\/li\u003e\n\u003cli\u003eKey partners: Ontario Cannabis Store, Alberta Gaming, Liquor and Cannabis\u003c\/li\u003e\n\u003cli\u003eTarget: keep out-of-stock \u0026lt;8% to protect market share\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/paurora\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAurora partnerships fuel 42% exports, cut costs 18%, and drive CA$120M exports\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAurora’s key partnerships — distributors (MedReleaf AU, EU pharmacy networks), Bevo Farms (2.4M seedlings\/yr), CROs\/academia (12 trials since 2023, \u0026gt;1,800 patients), regulators (Health Canada, BfArM), and provincial wholesalers (OCS, AGLC) — drove 42% of FY2025 exports, cut input costs ~18%, and supported CA$120m industry exports (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003ePartner\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024–25\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003eExport share\u003c\/td\u003e\n\u003ctd\u003e42% FY2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBevo Farms\u003c\/td\u003e\n\u003ctd\u003eSeedlings\/yr\u003c\/td\u003e\n\u003ctd\u003e2.4M (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCROs\/Academia\u003c\/td\u003e\n\u003ctd\u003eTrials \/ pts\u003c\/td\u003e\n\u003ctd\u003e12 \/ 1,800+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulators\u003c\/td\u003e\n\u003ctd\u003eIndustry exports\u003c\/td\u003e\n\u003ctd\u003eCA$120M (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProvincial wholesalers\u003c\/td\u003e\n\u003ctd\u003eRetail sales\u003c\/td\u003e\n\u003ctd\u003eCAD 4.5B (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, ready-made Business Model Canvas for Aurora covering customer segments, value propositions, channels, revenue streams, key resources and partners, cost structure, and activities with narrative insights, SWOT-linked analysis, and investor-ready presentation formatting to support strategic decisions and funding discussions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Aurora’s strategy into a digestible, one-page canvas with editable cells—saving hours of formatting while enabling quick comparisons, team collaboration, and fast executive summaries for boardrooms or workshops.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision Cultivation and Processing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAurora runs large-scale, automated cultivation in EU-GMP certified plants, achieving yields up to 80–120 g\/m2 per harvest and reducing OPEX per gram by ~25% versus manual grows; FY2024 cultivation revenue contribution was ~57% of COGS in EU operations. The processing stage uses CO2 and ethanol extraction plus winterization and chromatography to produce medical-grade oils, vapes, and concentrates, supporting gross margins near 48% on finished products in 2024. This precision cultivation-to-processing pipeline converts low-margin biomass into high-value pharmaceutical and consumer SKUs, driving SKU-level ASPs of €35–€120. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenetic Research and Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAurora invests ~CA$45m annually in breeding and lab R\u0026amp;D, developing proprietary cannabis genetics with targeted cannabinoid and terpene profiles to boost potency and disease resistance and tailor strains for conditions like chronic pain and epilepsy; owning these cultivars helped Aurora register 12 IP filings by 2024, creating a differentiated product line that's costly for competitors to replicate.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Regulatory Compliance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAurora spends ~22% of operational hours on global regulatory compliance, maintaining EU-GMP certification (required for EU exports) and other country-specific accreditations; these controls cut batch rejection rates to 1.8% in 2024 and supported €48M in EU sales that year. Constant legal monitoring and QA updates ensure each shipment meets destination laws, avoiding fines (zero major penalties since 2022).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBrand and Product Portfolio Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAurora manages a house of brands from premium medical labels to value recreational lines, using targeted marketing, packaging design, and SKU rationalization to respond to shifting consumer tastes; brand mix helped secure ~CA$1.4B of 2024 revenue and sustained average realized prices 8–12% above commodity peers.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eStrategic marketing: segmented campaigns, 20% higher ROI on premium SKUs\u003c\/li\u003e\n\u003cli\u003ePackaging \u0026amp; design: reduced returns 15% in 2024\u003c\/li\u003e\n\u003cli\u003eProduct lifecycle: retired 12 low-margin SKUs in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Patient Intake and Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eProviding seamless onboarding for medical patients, Aurora verifies prescriptions and offers personalized consultations via dedicated support centers that handled ~120,000 medical patient interactions in 2024, improving adherence and outcomes.\u003c\/p\u003e\n\u003cp\u003eThis high-touch model—consults, product selection, dosage guidance—boosts retention; medical segment LTM revenue was C$85M in 2024, with patient repeat rate ~62%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eVerify prescriptions, clear exceptions\u003c\/li\u003e\n\u003cli\u003ePersonalized consultations on dosing\u003c\/li\u003e\n\u003cli\u003eSupport centers handle ~120k cases (2024)\u003c\/li\u003e\n\u003cli\u003eMedical revenue C$85M LTM (2024)\u003c\/li\u003e\n\u003cli\u003eRepeat rate ~62%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAurora: CA$1.4B revenue, 48% gross margin, 80–120 g\/m² yield, C$85M medical income\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAurora operates EU-GMP automated cultivation and CO2\/ethanol processing, yielding 80–120 g\/m2 per harvest, 48% finished-product gross margin (2024), and CA$1.4B revenue; R\u0026amp;D spend CA$45M\/year, 12 IP filings (2024); compliance workload 22% ops hours, 1.8% batch rejection; medical support handled ~120k interactions, C$85M medical revenue, 62% repeat rate.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eYield (g\/m2)\u003c\/td\u003e\n\u003ctd\u003e80–120\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin (finished)\u003c\/td\u003e\n\u003ctd\u003e48%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003eCA$1.4B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D spend\u003c\/td\u003e\n\u003ctd\u003eCA$45M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIP filings\u003c\/td\u003e\n\u003ctd\u003e12\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBatch rejection\u003c\/td\u003e\n\u003ctd\u003e1.8%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical interactions\u003c\/td\u003e\n\u003ctd\u003e120,000\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical revenue\u003c\/td\u003e\n\u003ctd\u003eC$85M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRepeat rate\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe preview shown is the actual Aurora Business Model Canvas you’ll receive—no mockups or samples. Upon purchase you’ll get this same complete, professionally formatted file ready to edit, present, and share in Word and Excel. What you see is what you’ll download: the full deliverable with all content included, instantly accessible and ready for use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56748983058809,"sku":"auroramj-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/auroramj-business-model-canvas.png?v=1772212160","url":"https:\/\/matrixbcg.com\/products\/auroramj-business-model-canvas","provider":"matrixbcg.com","version":"1.0","type":"link"}